Diana Barb

机构：University of Florida Health, University of Florida · ORCID：0000-0001-5208-6828

发表论文 71 篇 · 总被引 6436 次 · h-index 22

代表论文

• AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease (2023 · Hepatology · 被引 2427)
• American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings (2022 · Endocrine Practice · 被引 981)
• Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association (2025 · Diabetes Care · 被引 276)
• Type 2 diabetes mellitus increases the risk of hepatic fibrosis in individuals with obesity and nonalcoholic fatty liver disease (2021 · Obesity · 被引 147)
• PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH (2021 · Liver International · 被引 99)
• The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (2024 · Clinical Gastroenterology and Hepatology · 被引 84)